series-c
(48)
The Cardiologist Who Wants to Grow Your Chicken Without the Chicken
A former heart doctor traded the cath lab for the bioreactor to grow chicken from cells. He made history, hit a $1 billion valuation, and then ran straight into state legislatures that would rather ban his product than taste it.
The Company That Turned Corporate Security Into a Single Screen
Corporate security teams drown in tabs, feeds and spreadsheets. Ontic bet that connecting all of it in one place - now with AI - is worth $287 million to investors and the attention of the Fortune 50.
The Korean Startup Trying to Shrink the Grid's Heaviest Box
Crocus wants to replace the hundred-year-old iron transformer with a silicon one that thinks. Its bet: the same box that charges electric cars can also keep an AI data center from browning out.
Touring Capital Is Betting $330 Million on AI After the Demo
The young San Francisco firm is skipping the loudest layer of the AI boom. Its wager is that the durable money will be made by software that fixes costly, stubborn work.
Product-Market Fit Is the Easy Part
Greenfield Partners, a TPG spinout running about $1 billion out of Tel Aviv and New York, invests at the exact moment most startups stall - and treats the climb from Series B to scale as an engineering problem, not a leap of faith.
The Company That Rents You a Sales Team in the Gulf - and the AI That Tells It Who to Call
Selling software into the Gulf usually means hiring locally, learning the market the hard way, and waiting months to get paid. Cadena turns that whole problem into a subscription.
bolttech
A Singapore insurtech quietly turned the checkout button into an insurance counter. Now 230 insurers and 700 partners run through its pipes.
Doctor Anywhere
Doctor Anywhere is a Singapore-headquartered, tech-led healthcare company founded in 2017 by Lim Wai Mun. It started as a telemedicine app that put a licensed doctor on a video call within minutes, then deliberately grew downward into the physical world - GP clinics, specialist practices, health screening and imaging suites, home visits, medication delivery and an in-app health marketplace. The company describes the result as a 'Hospital Anywhere' model: one app that carries a patient from a 2am sore throat to a knee surgeon, across Singapore, Malaysia, Thailand, Indonesia and the Philippines. It serves roughly 3 million users, sells to consumers, corporates and insurers, and has raised about US$176 million from investors including Asia Partners, Novo Holdings, Square Peg, EDBI, IHH Healthcare, Philips and Pavilion Capital.
AcuityMD
AcuityMD is a Boston-based commercial intelligence platform built specifically for the medical device (MedTech) industry. It translates large volumes of healthcare claims and procedure data into intuitive workflows, AI-powered insights, and recommendations that help medical device sales and marketing teams find high-value physicians and care sites, size and segment markets, manage territories, and accelerate product adoption. Founded in 2019 by former MedTech and consulting operators, the company serves hundreds of device makers - including a majority of the largest MedTech firms - and raised an $80M Series C in 2026 at a near-$1B valuation.
Botrista, Inc.
Botrista is a San Francisco-based food-and-beverage technology company that builds an AI-driven automated beverage platform. Its flagship BotristaPro machine lets restaurants, campuses, hospitals, theme parks and other venues serve a wide range of craft cold drinks - boba teas, smoothies, refreshers, cold brew, lemonades and more - from a single compact, self-cleaning unit in seconds, without specialized baristas. Founded in 2017 by former Tesla automation engineer Sean Hsu, the company pairs patented multi-ingredient dispensing hardware with cloud-based analytics and demand forecasting, and has raised roughly $126 million to date, including a Series C led by Jollibee Foods Corporation.
Cloudsmith
Cloudsmith is a Belfast-founded, cloud-native artifact management platform that gives engineering teams a single place to store, secure, and distribute software packages and containers across 30+ formats. It acts as a private, fully managed registry with built-in supply chain controls - vulnerability and malware scanning, policy enforcement, quarantine, and global distribution - increasingly positioned around governing the flood of code produced by AI coding agents.
Diana Health
Diana Health is a women's healthcare company that partners with hospitals to redesign their OB-GYN and labor-and-delivery programs around a midwifery-centered, team-based care model. Certified nurse-midwives work alongside OB-GYNs, therapists, dietitians, and health coaches to deliver longer appointments, integrated mental health, and holistic support across pregnancy, gynecology, menopause, and everyday well-woman care - backed by a digital platform for education and virtual visits. Founded in 2020 and based in New York, the company operates clinics co-located with mid-sized hospitals and serves more than 80,000 women a year.
Kontakt.io
Kontakt.io is an AI-powered real-time location system (RTLS) and care-operations platform for hospitals. Starting in 2013 as a Krakow Bluetooth-beacon maker, it now combines IoT sensors, wearable tags and cloud AI to track the location, status and flow of patients, staff and equipment across health systems - helping hospitals cut wasted time, find assets, protect staff and orchestrate care around each patient's journey. It has deployed 4M+ IoT devices, serves 32,000+ end users, and raised a $47.5M Series C led by Goldman Sachs in 2024.
Ledgebrook
Ledgebrook is a tech-enabled excess and surplus (E&S) lines managing general agent (MGA) that aims to give wholesale insurance brokers the fastest, easiest quoting experience. Founded in 2021 by former actuary Gage Caligaris, the company pairs a next-generation tech stack - which enriches and prefills broker submissions and speeds rating - with experienced human underwriters to write specialty commercial coverages such as general liability, excess liability, professional liability, allied healthcare, and architects & engineers. Having written its first policy in May 2023, Ledgebrook passed a $100M premium run rate and closed an oversubscribed $65M Series C in June 2025, bringing total funding to roughly $119M.
Steno
Steno is a Los Angeles-based legal technology company that combines a nationwide network of certified court reporters with purpose-built litigation software and flexible financing. It handles the logistics of depositions and trials - scheduling reporters, videographers and interpreters, running remote proceedings through Steno Connect for Zoom, deferring payment via DelayPay, and analyzing transcripts with its generative-AI tool Transcript Genius - so litigators can focus on their cases instead of the paperwork behind them.
WeTravel
WeTravel is a fintech and SaaS platform built specifically for multi-day, group and tour travel businesses. It lets operators create branded booking pages, collect deposits and staged installment payments in multiple currencies, manage traveler details, pay suppliers, and build AI-assisted itineraries - all from one dashboard. Founded in 2016 by three immigrant entrepreneurs who met at UC Berkeley, the company has processed trips in 206 countries for more than 1.6 million travelers and raised $126M in total funding, including a $92M Series C led by Sapphire Ventures in September 2025.
Anrok
Anrok is a San Francisco fintech building a global sales tax, VAT and GST compliance platform for software and AI companies. It monitors sales activity to flag tax obligations across jurisdictions, calculates tax in real time, and automates filing, remittance and reporting. More than 3,000 finance teams - including Anthropic, Cursor and Notion - use Anrok across 100+ countries where digital products are taxable.
Attovia Therapeutics
Attovia Therapeutics is a San Carlos, California clinical-stage biotech developing first-in-class multispecific biologics for immune-mediated diseases. Its proprietary ATTOBODY platform builds small-format, biparatopic nanobody medicines with ultra-high (picomolar) affinity, tunable half-life and fast tissue penetration - engineered to hit multiple disease pathways at once. Lead programs ATTO-1310 (anti-IL-31) and ATTO-3712 (IL-13 x IL-31 bispecific) target chronic pruritus and atopic dermatitis. Founded in 2023 out of an Alamar Biosciences and Frazier Life Sciences incubation, the company has raised roughly $255M across Series A through C.
Inquis Medical, Inc.
Inquis Medical is a Silicon Valley medical device company founded in 2020 by serial medtech entrepreneurs Vahid and Mojgan Saadat. Its flagship AVENTUS Precision Thrombectomy System removes blood clots from patients with pulmonary embolism (PE) and deep vein thrombosis (DVT), using proprietary TrueClot tissue-sensing technology that gives physicians real-time feedback to distinguish blood, clot, and vessel wall while minimizing blood loss through autologous blood reinfusion. Backed by $115M in total funding including a $75M Series C in January 2026, the company is scaling nationwide commercial adoption after winning FDA 510(k) clearance for PE in 2025.
Lycia Therapeutics
Lycia Therapeutics is a South San Francisco biotech building lysosomal targeting chimeras (LYTACs) - bifunctional molecules that drag disease-driving extracellular and membrane proteins into the cell's lysosomes for destruction. Founded in 2019 out of the lab of Nobel laureate Carolyn Bertozzi, Lycia is advancing a pipeline of autoimmune and inflammatory disease therapies, backed by $226M+ in venture capital and a strategic discovery collaboration with Eli Lilly.
Seurat Technologies
Seurat Technologies is a Massachusetts-based contract metal manufacturer built around Area Printing, a laser powder bed fusion process invented at Lawrence Livermore National Laboratory. Instead of melting metal powder one point at a time, Seurat uses millions of tiny laser points to print entire areas at once, decoupling resolution from speed. The company doesn't sell printers; it runs its own clean-energy print factories and sells finished parts at costs meant to rival casting, forging, and machining, with the goal of reshoring high-volume metal manufacturing and cutting its carbon footprint.
TORL BioTherapeutics LLC
TORL BioTherapeutics is a clinical-stage biopharmaceutical company in Culver City, California developing antibody-based cancer therapies, including antibody-drug conjugates (ADCs) and monoclonal antibodies. Built on discoveries from the UCLA laboratory of Dennis Slamon - the scientist behind Herceptin and Ibrance - TORL is advancing a pipeline against novel cancer targets such as Claudin 6, Claudin 18.2, CDH17, and DLK1. Its lead program, TORL-1-23 (ixotatug vedotin), a CLDN6-targeted ADC, is in pivotal trials for platinum-resistant ovarian cancer. The company has raised over $450 million across multiple rounds, including a $96 million Series C in October 2025.
Cents
Cents is the all-in-one business management platform for the laundry and garment care industry. It pairs point-of-sale software, on-machine payments, pickup-and-delivery logistics, marketing automation and AI customer service into a single system used by more than 4,500 laundromat and dry-cleaning locations. Founded in New York in 2019, Cents has raised roughly $185M, including a $140M Series C in 2026, to modernize an industry of 90,000+ retail laundry businesses that long ran on quarters, paper tickets and hand-written ledgers.
Suno
Suno is a Cambridge, Massachusetts company building generative-AI tools that turn a text prompt into a full song - vocals, instruments, and lyrics - in seconds. Founded by four former Kensho machine-learning engineers who were also musicians, Suno has grown into one of the most-used consumer AI apps, with tens of millions of users generating millions of tracks a day. It rode a string of rapid model releases (v3 through v5) and an in-browser DAW called Suno Studio to roughly $300M in annual recurring revenue and a $5.4B valuation, all while fighting - and beginning to settle - copyright lawsuits from the major record labels.
Ambience Healthcare
Ambience Healthcare builds an ambient AI platform for clinicians - an AI medical scribe and coding assistant that listens to patient visits, drafts structured notes in seconds, and pushes compliant ICD-10/CPT coding back into Epic, Cerner, and athenahealth. It is used by Cleveland Clinic, UCSF Health, Houston Methodist, Memorial Hermann and dozens of other systems.
Arine
Arine is a San Francisco-based medication intelligence company using AI, predictive analytics, and clinical workflows to identify patients at risk of medication-related problems and generate personalized care plans. Its platform serves more than 30 health plans, has touched over 30 million lives, and is designed to cut hospitalizations and the cost of care while lifting CMS Star Ratings.
Arize AI
Arize AI builds the observability layer for AI - a platform engineers use to trace, evaluate, and debug models, agents, and LLMs running in production. Its open-source Phoenix library and enterprise platform are used by companies like Uber, DoorDash, Instacart, Reddit, Booking.com, and Duolingo to make AI systems work in the real world.
Brightside Health
Brightside Health is a national virtual mental healthcare company delivering psychiatry, therapy and crisis care for people with depression, anxiety, and elevated suicide risk - powered by a proprietary AI platform and a 50-state clinician network, with coverage through major commercial insurers, Medicare and Medicaid.
Cowbell
Cowbell is a Pleasanton-based insurtech that sells adaptive cyber insurance to small and mid-sized businesses, using an AI-driven continuous underwriting platform that scores cyber risk and can issue a policy in under five minutes.
Homebound
Homebound is a tech-enabled homebuilder headquartered in San Francisco that manages the entire home construction process from design to move-in. Founded in 2018 in the wake of the devastating California wildfires, the company combines a proprietary software platform with a vetted trade partner network to offer semi-custom homes at fixed prices. Homebound handles everything from lot sourcing and permitting to interior design and construction management, compressing what typically takes years into an industry-leading timeline. With over $308 million raised and 500+ homes built across markets in California, Texas, Colorado, and Florida, Homebound is rewriting the rules of residential construction for a new generation of homebuyers.